VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. - Gragoudas,E.S.; Adamis,A.P.; Cunningham,E.T Jr. (N Engl J Med, 2004)